Lesinurad Patent Expiration
Lesinurad is Used for reducing serum uric acid levels, treating gout, and managing hyperuricemia in patients unresponsive to xanthine oxidase inhibitors alone. It was first introduced by Ironwood Pharmaceuticals Inc
Lesinurad Patents
Given below is the list of patents protecting Lesinurad, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zurampic | US8546436 | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof | Feb 29, 2032 | Ironwood Pharms Inc |
| Zurampic | US9956205 | Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof | Dec 28, 2031 | Ironwood Pharms Inc |
| Zurampic | US9216179 | Treatment of gout and hyperuricemia | Aug 01, 2031 | Ironwood Pharms Inc |
| Zurampic | US8357713 | Compounds and compositions and methods of use | Dec 22, 2029 | Ironwood Pharms Inc |
| Zurampic | US8084483 | Compounds and compositions and methods of use | Aug 17, 2029 | Ironwood Pharms Inc |
| Zurampic | US8546437 | Compounds and compositions and methods of use | Apr 29, 2029 | Ironwood Pharms Inc |
| Zurampic | US10183012 | Compounds and compositions and methods of use | Nov 26, 2028 | Ironwood Pharms Inc |
| Zurampic | US8283369 | Compounds and compositions and methods of use | Nov 26, 2028 | Ironwood Pharms Inc |
| Zurampic | US8003681 | 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester | Aug 25, 2025 | Ironwood Pharms Inc |
Lesinurad's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List